bullish

$STVN: are oral GLP-1s really a death blow? | Aurelian Research's Leo Trudel

235 Views10 May 2026 03:34
Podcast
SUMMARY
  • Stevenato is a company that provides containment delivery systems for large pharma companies.
  • Their customers include major pharmaceutical companies like Eli Lilly, Novo Nordisk, Pfizer, and Moderna.
  • The company experienced significant growth during the pandemic due to the demand for their glass vials for vaccines, but is now facing challenges with overbuilding and potential destocking issues.

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only.

Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
Discussions
(Paid Plans Only)
chart-bar
Price Chart(Sign Up to Access)
analytics-chart
  • $STVN: are oral GLP-1s really a death blow? | Aurelian Research's Leo Trudel
    10 May 2026
x